AUM $570.6MER 0.35%NAV $74.10Holdings 65Inception Jun 2006
Price Chart
Key Statistics
Previous Close
$73.57Day Range
$72.60$73.50
52-Week Range
$45.82$74.06
Avg Volume
108.0KDividend Yield
0.84%Expense Ratio
0.35%AUM
$570.6MShares Outstanding
4.0METF Grades
?ETF Grades compare this fund against others in the same category using percentile rankings across six factors. Grades range from A+ (top 5%) to F (bottom 20%). Updated daily.Sector Breakdown
| Sector | Weight % |
|---|---|
| Healthcare | 100.00% |
Country Allocation
| Country | Weight % |
|---|---|
| United States | 96.62% |
| Ireland | 3.29% |
| Other | 0.09% |
Fund Information
- Issuer
- SPDR
- Category
- Healthcare
- Inception Date
- Jun 19, 2006
- Exchange
- NYSE_ARCA
- Description
- The State Street SPDR S&P Pharmaceuticals ETF seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the S&P Pharmaceuticals Select Industry Index (the "Index")Seeks to provide exposure to the pharmaceuticals segment of the S&P TMI, which comprises the Pharmaceuticals sub-industrySeeks to track a modified equal weighted index which provides the potential for unconcentrated industry exposure across large, mid and small cap stocksAllows investors to take strategic or tactical positions at a more targeted level than traditional sector based investing
Similar ETFs
The State Street SPDR S&P Pharmaceuticals ETF (XPH) is an exchange-traded fund issued by SPDR that launched on Jun 19, 2006. It currently manages $570.6M in assets under management. The fund charges an expense ratio of 0.35%. The fund holds 65 securities in its portfolio. It falls under the Healthcare category.
Top 10 holdings represent 27.5% of the fund
| Rank | Symbol | Name | Weight % | Shares | Market Value |
|---|---|---|---|---|---|
| 1 | AMLX | AMYLYX PHARMACEUTICALS INC | 4.19% | 608,077 | $23.9M |
| 2 | CRNX | CRINETICS PHARMACEUTICALS IN | 3.51% | 238,482 | $20.0M |
| 3 | MBX | MBX BIOSCIENCES INC | 3.05% | 264,107 | $17.4M |
| 4 | ATAI | ATAIBECKLEY INC | 2.79% | 2,165,255 | $15.9M |
| 5 | DFTX | DEFINIUM THERAPEUTICS INC | 2.78% | 352,180 | $15.9M |
| 6 | OMER | OMEROS CORP | 2.60% | 802,417 | $14.8M |
| 7 | ELVN | ENLIVEN THERAPEUTICS INC | 2.27% | 221,207 | $12.9M |
| 8 | CORT | CORCEPT THERAPEUTICS INC | 2.21% | 104,775 | $12.6M |
| 9 | NUVB | NUVATION BIO INC | 2.12% | 1,787,045 | $12.1M |
| 10 | ETON | ETON PHARMACEUTICALS INC | 2.01% | 193,331 | $11.5M |
| 11 | TRVI | TREVI THERAPEUTICS INC | 1.94% | 610,798 | $11.1M |
| 12 | EWTX | EDGEWISE THERAPEUTICS INC | 1.87% | 248,619 | $10.7M |
| 13 | NKTR | NEKTAR THERAPEUTICS | 1.87% | 144,145 | $10.7M |
| 14 | OCUL | OCULAR THERAPEUTIX INC | 1.81% | 936,462 | $10.3M |
| 15 | MRK | MERCK + CO. INC. | 1.78% | 68,734 | $10.2M |
Page 1 of 2
Detailed Returns
| Period | Return | ETF |
|---|---|---|
| 1D | -0.87% | |
| 1W | +0.66% | |
| 1M | +6.41% | |
| 3M | +24.50% | |
| 6M | +27.19% | |
| YTD | +32.10% | |
| 1Y | +54.78% | |
| 3Y | +67.54% | |
| 5Y | +50.84% |
Moving Averages
20-Day MA
$70.72
Above 20-Day MA50-Day MA
$68.05
Above 50-Day MA200-Day MA
$58.96
Above 200-Day MAPrice with Moving Averages
Support & Resistance
52-Week High
$74.06
Current Price
$72.93
52-Week Low
$45.82
$45.82$74.06
Current Yield
0.84%
Annual Dividend
$0.3460
Frequency
Quarterlyx/year
Last Ex-Date
Jun 22, 2026
Dividend History
| Ex-Date | Amount | Pay Date |
|---|---|---|
| Jun 22, 2026 | $0.0590 | Jun 24, 2026 |
| Mar 23, 2026 | $0.0610 | Mar 25, 2026 |
| Dec 22, 2025 | $0.1130 | Dec 24, 2025 |
| Dec 22, 2025 | $0.1130 | Dec 24, 2025 |
| Sep 22, 2025 | $0.1026 | Sep 24, 2025 |
| Sep 22, 2025 | $0.1026 | Sep 24, 2025 |
| Jun 23, 2025 | $0.0959 | Jun 25, 2025 |
| Mar 24, 2025 | $0.1533 | Mar 26, 2025 |
| Mar 24, 2025 | $0.1533 | Mar 26, 2025 |
| Dec 23, 2024 | $0.1548 | Dec 26, 2024 |
| Dec 23, 2024 | $0.1548 | Dec 26, 2024 |
| Sep 23, 2024 | $0.1947 | Sep 25, 2024 |
| Sep 23, 2024 | $0.1947 | Sep 25, 2024 |
| Jun 24, 2024 | $0.1557 | Jun 26, 2024 |
| Jun 24, 2024 | $0.1557 | Jun 26, 2024 |
| Mar 18, 2024 | $0.1730 | Mar 21, 2024 |
| Mar 18, 2024 | $0.1730 | Mar 21, 2024 |
| Dec 18, 2023 | $0.1744 | Dec 21, 2023 |
| Dec 18, 2023 | $0.1744 | Dec 21, 2023 |
| Sep 18, 2023 | $0.1201 | Sep 21, 2023 |
Dividend Payments Over Time
Category Comparison
| Metric | XPH | Healthcare(223 ETFs) | Equal Weight(109 ETFs) |
|---|---|---|---|
| Fund Info | |||
| Expense Ratio | 0.35% | 0.62% | 0.68% |
| AUM | $570.6M | $1.98B | $1.76B |
| Dividend Yield | 0.84% | 3.90% | 2.88% |
| Avg Volume | 108.0K | 422.1K | 456.8K |
| Holdings | 65 | 167 | 194 |
| Performance | |||
| 1-Month Return | +8.10% | +6.56% | +3.97% |
| 6-Month Return | +29.96% | +16.09% | +12.76% |
| YTD Return | +31.35% | +16.75% | +15.98% |
| 1-Year Return | +35.51% | +15.10% | +14.92% |
Compare with Another ETF
Search for an ETF to compare with XPH:
FREE DOWNLOAD
The Beginner's Guide to ETFs
20 pages. Zero fluff. Everything you need to start investing in ETFs.
No spam. Unsubscribe anytime.